HUE028031T2 - Makula pigmenteket tartalmazó xantofill készítmény és eljárás elõállítására - Google Patents

Makula pigmenteket tartalmazó xantofill készítmény és eljárás elõállítására Download PDF

Info

Publication number
HUE028031T2
HUE028031T2 HUE10760417A HUE10760417A HUE028031T2 HU E028031 T2 HUE028031 T2 HU E028031T2 HU E10760417 A HUE10760417 A HU E10760417A HU E10760417 A HUE10760417 A HU E10760417A HU E028031 T2 HUE028031 T2 HU E028031T2
Authority
HU
Hungary
Prior art keywords
zeaxanthin
lutein
ják
composition
ben ben
Prior art date
Application number
HUE10760417A
Other languages
English (en)
Inventor
T K Sunil Kumar
Abdulkadir Sherena P
Original Assignee
Omniactive Health Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43216969&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE028031(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omniactive Health Tech Ltd filed Critical Omniactive Health Tech Ltd
Publication of HUE028031T2 publication Critical patent/HUE028031T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (4)

Szabadalmi iggnypomfc
1. XantöíiM amely transz-iuteinbói álló tnakuía pigmenteket, »abba mmmtis izomereket, »evezessen (R,R)-zeaxantint és {R.Sr-zesxanóot tartalmaz, xzmotliekemxantonlbeszterekel tartalmazó növényi ex^Äumbdi/gyaniÄtssaiaiä iióöla|bóí kzármárik, emberi fogyasztás szempontjából biztonságos ék táplálkozásra és egészség támogatására alkalmas, amely készítmény tartalmaz. legalább 88 tőtneg%-bao teljes xaaioriilsfcst, aboi a. bsnszfoitelo és a zeáxsotin Izomerek aránya 4:| - ő: 1 t&nomáoyban vsa, és a zeaxamát Izomereinek mártva 88-20 :20-80 tartományban van.
2. As I, Igénypctnt szerinti xantofli készitmétîy, amely készltrnéaÿ legalább $$ tömegifo-bsm tartalmaz teljes támlára legalább Í5%,
3. Az 1. Igénypont szerinti xantofül készítmény, amely készítmény tartalmaz legalább 85 tömeg%-baa teljes xsmotiileket, amelyek legalább 88 tómeg%-a transz-latéin, a maradék I S tőnreg%-oí zeaxaniln izomerek, oe^ezei&^o: (R,^zssmr^m és ÍRyS)rzemrnmt teszik ki,
4. Kijárás xantoffi le^itmény előállítására, amely készítmény íransz-foíemból álló rnaknía pgmestekgb továbbá zeaxarílln Izxsmereket, nevezetesen (R,R)-zeaxantíiít és CfoSl-zeax&amp;ntfoí tartalmaz, xartloftlle-ketfomoillfosztetekéí tartalmazó növényi exbraktamböl/gyamatarfoimö illóoiapiól származik, emberi fogyasztás szempontjából biztonságos és táplálkozásra és egészség támogatására alkabrsas^ arasly óprás során 0:: eiszappatmsiíjbfc és egyipjbieg: ÉÉf IzeperMljitk a xsntoftíi-észtereket tastábsaM növényi jelenlévő jmmeílll-észíermtet az emmkámt%yamaíartalmá Illóolaj: és l-propanol logos oldata összekeverésével, abol a lag és az: l-propapól aránya 1:8,5- 1:1 tönregÁérfogat tartományban van, a képződött masszát 7%4W*C tartományba esë bőmérsékfotefo előnyösen ÿS'Om melegítjük 1-5 óra tartományba eső ideig, Így elszappanositött/izomerizált nyers koneentrátumot kopunk; |b| »2 (a) lépésben kapott élszappanositott/lzomerizált vízzel, ábol a koneenbáium és az alkalmazott víz aránya 1:2 - 1 ;3 térfogat-térfogat tartonfonyban van, így bfotíotr olajos keveréket kapónk; fo| a (b) lépésben kap®&amp; .1^1^ keveréket, etfoaeetábál sxtmbáljuki óbói á Bígított elmos keverék és az: alkalmazok etil-aeetát aránya 1:1,5 -1:2 téribgat/tótfogaí tariötnányhaa van, így xmí&amp;M készítményt tartalmazói extraktinnot kapónk; {0. a (c)lépésbe« kapoRMszÖPranyi hepáfoíya éMvóffijuk az etil-aeeiátoR 1«| a (ö) lépésből szánkás® készítményt először ném-poiáres, majiá poláros oldószerekkel: végzet mosás-mű Iá szűréssel dsátífosk; Φ afrépndőít készítményt Vákuumban 40-45süi tartományba eső Mmérsékísten 41-22 óra tartományba eső ideig sztórijak; (g) kívánt esethez a (c) lépésben alkalmazott ebi-aceíátoí szokásos eljárásokkal kiinyerjűk, és kívánt esetben rjrabasznosfotlk; és (h) a képződött készítményt mert légtérben -20c€-on tároljuk. $< &amp; 4. ígé:Gyp<s#; xzemît sprás, érni m afctasxo« xarÂÊl-észisrskat íarplmazá áövéHp extrák-ivmtgj'antatsnaimü üíóolaj körömvirág virágaiból származik. 4 A 4. ás 5. i§àsÿ|5ôî5t szerinti eí|áfáS:, aáöi m (é$ Misben alkalmaxöö Rám-pelárös eiáós&amp;sít pepán, àexââ ás ügtfte kózól kiválasztott szásktirögen oldószerek közti választják, smsív éi®m#seö fcex&amp;a, ás m Æskmzm pcMsrm dMmm rôvë&amp;æéitèmà ûMBsÆ&amp;ko^k&amp;zëlWimj^
HUE10760417A 2009-09-02 2010-09-02 Makula pigmenteket tartalmazó xantofill készítmény és eljárás elõállítására HUE028031T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2008MU2009 2009-09-02
US25666709P 2009-10-30 2009-10-30

Publications (1)

Publication Number Publication Date
HUE028031T2 true HUE028031T2 (hu) 2016-11-28

Family

ID=43216969

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE10760417A HUE028031T2 (hu) 2009-09-02 2010-09-02 Makula pigmenteket tartalmazó xantofill készítmény és eljárás elõállítására

Country Status (14)

Country Link
US (1) US10485833B2 (hu)
EP (1) EP2473065B1 (hu)
JP (1) JP5778676B2 (hu)
KR (1) KR101479821B1 (hu)
CN (1) CN102481011B (hu)
AU (1) AU2010290970B2 (hu)
CA (1) CA2771967C (hu)
DK (1) DK2473065T3 (hu)
ES (1) ES2568937T3 (hu)
HU (1) HUE028031T2 (hu)
IL (1) IL218240A0 (hu)
PL (1) PL2473065T3 (hu)
PT (1) PT2473065E (hu)
WO (1) WO2011027209A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
EP2729217B1 (en) * 2011-07-07 2018-05-30 Howard Foundation Holdings Limited Method for improving glare disability
CN103566049B (zh) * 2012-08-08 2017-08-04 浙江医药股份有限公司新昌制药厂 用于提高眼睛中视黄斑色素密度并预防或治疗年龄相关性视黄斑衰退症的组合物
RU2649618C2 (ru) * 2012-12-19 2018-04-04 Новас Интернэшнл Инк. Ксантофильные композиции и способы их применения
CN105120853A (zh) * 2013-03-28 2015-12-02 奥米尼埃克蒂夫健康科技有限公司 类胡萝卜素的脑内神经保护作用
EP3122339A2 (en) * 2014-03-28 2017-02-01 Omniactive Health Technologies Ltd. Effect of lipophilic nutrients on diabetic eye diseases
WO2016139605A1 (en) 2015-03-02 2016-09-09 Omniactive Health Technologies Limited Method for stress management and overall health status improvement and compositions used therein
US10532035B2 (en) 2015-03-26 2020-01-14 Omniactive Health Technologies Limited Methods for improvement of visual function and compositions used therein
WO2017056024A1 (en) * 2015-09-28 2017-04-06 Omniactive Health Technologies Limited Xanthophyll compositions for skin lightening
JP6077159B1 (ja) * 2016-03-30 2017-02-08 アサヒ飲料株式会社 飲料及びルテインの飲料中安定性を調節する方法
WO2017179028A1 (en) * 2016-04-16 2017-10-19 Omniactive Health Technologies Limited Method for treatment of visual stress conditions and compositions used therein
CN105969725B (zh) * 2016-06-12 2019-04-26 暨南大学 枸杞红素的用途
CN107802619A (zh) * 2017-12-06 2018-03-16 北京市眼科研究所 一种用于眼部健康的浓缩物
WO2020065484A1 (en) * 2018-09-26 2020-04-02 Omniactive Health Technologies Limited Purified xanthophyll composition comprising (trans,r,r)- lutein and(trans,r,r)- zeaxanthin and process for the preparation thereof
US11090274B2 (en) * 2019-03-13 2021-08-17 Stuart Richer Consulting, LLC Formulation and method for supporting retinal health thereby reducing the risk of age-related macular degeneration (AMD)
CN114502147A (zh) * 2019-10-15 2022-05-13 奥米尼埃克蒂夫健康科技有限公司 包含黄体素和玉米黄质的具有增强的生物利用度的叶黄素组合物
KR20240034947A (ko) 2022-09-07 2024-03-15 전북대학교산학협력단 크립토캅신과 루테인을 주성분으로 하는 복합 추출물 및 그의 제조방법

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148133B1 (ko) 1989-08-30 1998-08-01 엘. 기르하르트 데니스 제아키산틴의 제조 및 제아키산틴 함유 조성물
US6329432B2 (en) 1993-06-28 2001-12-11 The Howard Foundation Mesozeaxanthin formulations for treatment of retinal disorders
US6218436B1 (en) 1993-06-28 2001-04-17 The Howard Foundation Pharmaceutically active carotenoids
US5382714A (en) 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5523494A (en) 1994-07-20 1996-06-04 Industrial Organica, S.A. De C.V. Process for the isomerization of lutein
AU719671B2 (en) 1995-06-07 2000-05-18 Howard Foundation, The Pharmaceutically active carotenoids
US5747544A (en) 1995-10-31 1998-05-05 Applied Food Biotechnology, Inc. Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
US5854015A (en) 1995-10-31 1998-12-29 Applied Food Biotechnology, Inc. Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US5827652A (en) 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
CA2188983C (en) 1995-10-31 2001-02-27 Kevin M. Garnett Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
CN1082507C (zh) * 1996-10-04 2002-04-10 霍夫曼-拉罗奇有限公司 叶黄素的转化方法
US5973211A (en) 1997-07-18 1999-10-26 Prodemex, S.A. De C.V. Pigmenting efficiency of a natural xanthophyll by isomerization
IT1293266B1 (it) 1997-07-23 1999-02-16 Consiglio Nazionale Ricerche Procedimento per l'assorbimento selettivo di ossidi di azoto.
PE130499A1 (es) 1997-10-31 1999-12-17 Bioquimex Reka S A De C V Procedimiento para la isomerizacion de luteina a zeaxantina y el producto obtenido con el mismo
US6075058A (en) 1998-12-12 2000-06-13 Tufts University Compositions for increased bioavailability of carotenoids
US6504067B1 (en) 1999-11-24 2003-01-07 Industrial Organica S.A. De C.V. Process to obtain xanthophyll concentrates of high purity
US7691406B2 (en) 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
DE10145223A1 (de) 2001-09-13 2003-04-03 Basf Ag Verfahren zur Herstellung von meso-Zeaxanthin
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US6737535B2 (en) 2002-06-05 2004-05-18 Kancor Flavours And Extracts Limited Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US6936279B2 (en) 2002-06-18 2005-08-30 Zeavision Llc Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
US6743953B2 (en) * 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
US7109361B2 (en) * 2003-03-07 2006-09-19 Nu-Tein Co., Inc. Isolation of lutein from alfalfa
US20070082066A1 (en) 2003-05-07 2007-04-12 Gierhart Dennis L Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
US7941211B2 (en) 2003-11-17 2011-05-10 Zeavision, Llc. Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
US7842722B2 (en) 2003-12-19 2010-11-30 Alcon, Inc. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US7351424B2 (en) 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US20060089411A1 (en) 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
WO2006114794A1 (en) * 2005-04-25 2006-11-02 Katra Phytochem Private Limited Isolation and purification of carotenoids from marigold flowers
US8481769B2 (en) 2005-04-25 2013-07-09 Katra Phytochem (India) Private Limited Isolation and purification of cartenoids from marigold flowers
CN1332947C (zh) * 2005-08-03 2007-08-22 浙江医药股份有限公司新昌制药厂 一种从植物油树脂中分离提纯叶黄素晶体的方法
US20070065487A1 (en) 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
AT503329A1 (de) 2006-03-02 2007-09-15 Omnica Gmbh Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält
US8212063B2 (en) * 2006-05-10 2012-07-03 Omniactive Health Technologies Limited Xanthophyll composition containing trans, meso-zeaxanthin, trans, R, R-zeaxanthin and trans, R, R-lutein useful for nutrition and health care and a process for its preparation
WO2009019712A1 (en) 2007-08-03 2009-02-12 Omniactive Health Technologies Pvt Ltd. Novel xanthophyll composition contaning (trans, meso) - zeaxanthin, and a process for its preparation

Also Published As

Publication number Publication date
AU2010290970A1 (en) 2012-03-15
ES2568937T3 (es) 2016-05-05
PT2473065E (pt) 2016-06-03
CN102481011A (zh) 2012-05-30
IL218240A0 (en) 2012-04-30
PL2473065T3 (pl) 2017-02-28
US10485833B2 (en) 2019-11-26
JP2013503844A (ja) 2013-02-04
CN102481011B (zh) 2015-04-15
CA2771967C (en) 2015-04-07
EP2473065B1 (en) 2016-04-13
JP5778676B2 (ja) 2015-09-16
WO2011027209A1 (en) 2011-03-10
DK2473065T3 (en) 2016-06-27
US20110065805A1 (en) 2011-03-17
CA2771967A1 (en) 2011-03-10
EP2473065A1 (en) 2012-07-11
KR101479821B1 (ko) 2015-01-06
AU2010290970B2 (en) 2014-12-04
KR20120083372A (ko) 2012-07-25

Similar Documents

Publication Publication Date Title
US10485833B2 (en) Xanthophyll composition containing macular pigments and a process for its preparation
EP2292598B1 (en) An improved process for the preparation of xanthophyll crystals
US8212063B2 (en) Xanthophyll composition containing trans, meso-zeaxanthin, trans, R, R-zeaxanthin and trans, R, R-lutein useful for nutrition and health care and a process for its preparation
US7271298B2 (en) Process for isolation and purification of xanthophyll crystals from plant oleoresin
US20080081932A1 (en) Method for Preparing High-Content Food-Grade Zeaxanthin
AU2002348718C1 (en) Novel trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US8871984B2 (en) Preparing method for xanthophyll crystals with higher content of zeaxanthin from plant oleoresin
WO2010138210A1 (en) Methods of saponifying xanthophyll esters and isolating xanthophylls
US20060020030A1 (en) Enhanced purity trans-lutein-ester compositions and methods of making same
EP1876883A2 (en) Ketocarotenoids from adonis palaestina
WO2009019712A1 (en) Novel xanthophyll composition contaning (trans, meso) - zeaxanthin, and a process for its preparation
US20220009886A1 (en) Manufacture of carotenoid compositions
US20040126338A1 (en) Process of converting trans-lutein into cis-lutein and the uses thereof